About
Laura A. Brege has served as a director of ACADIA since May 2008. Ms. Brege has been Chief Executive Officer and President of Nodality, Inc., a private company focused on innovative personalized medicine, since September 2012. Prior to joining Nodality, Ms. Brege held several senior-level positions at Onyx Pharmaceuticals, Inc. from June 2006 to December 2011, including Executive Vice President and Chief Operating Officer. Before joining Onyx, Ms. Brege was a general partner at Red Rock Capital Management, a venture capital firm specializing in early stage financing for technology companies. Prior to Red Rock, she was Senior Vice President and Chief Financial Officer at COR Therapeutics. Earlier in her career, Ms. Brege served as Vice President and Chief Financial Officer at Flextronics and Vice President and Treasurer of The Cooper Companies. Ms. Brege serves on the boards of Pacira Pharmaceuticals, Inc. and The Ohio University Foundation. Ms. Brege earned her undergraduate degree fro
Position in the VCSift Database
- • 13 investors hold the Member of Board of Directors role in VCSift. Laura A. Brege is one of them.
- • 7,285 investors are based in San Francisco, California, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- San Francisco, US
Contact Information
Find more investors like Laura
Search Investors